- Brand name eyeglasses, Frames, contact lenses, Sunglasses, Safety Glasses, and Quality Replacement Lenses at the most affordable prices

Shop Our Products


Abicipar maintains vision gain in wet AMD with less frequent dosing

Visual gains attained in year 1 of the CEDAR and SEQUOIA trials sustained effectively with four injections of abicipar as with 12 injections of ranibizumab in year 2, according to data from the virtual American Society of Retina Specialists meeting. Further, mathematical model simulations predicted longer duration of treatment effect. The CEDAR and SEQUOIA studies demonstrated that abicipar pegol, either at 8-week or 12-week dosing intervals, was noninferior to ranibizumab given monthly in terms...

>Read More

American Academy of Optometry to host virtual 2020 meeting

The AAO announced its decision to host this years meeting, renamed Academy 2020 At Home, on an online platform. We listened to our stakeholders and watched the national health situation very carefully, including the impact on Nashville, and we absolutely believe this is the best decision for everyone, Peter Scott, CAE, APR, MBA, CEO of the academy, said in a press release. While were disappointed that we cant hold this show in person, Im extremely excited to announce that weve found a dynamic an...

>Read More

Sight Sciences begins enrollment in ORION study

Sight Sciences has initiated patient enrollment in the ORION clinical study of the Omni surgical system in pseudophakic eyes, according to a press release. The prospective, multicenter clinical trial will include more than 110 patients with mild to moderate glaucoma at 10 sites across the U.S. The primary endpoint is the proportion of eyes with at least a 20% decrease in unmedicated mean diurnal IOP at 12 months. Secondary endpoints include the mean change in diurnal IOP from baseline and the pr...

>Read More

Light therapy repairs color contrast sensitivity in older patients

Researchers exploring mitochondrial function in patients with age-related visual decline found that light therapy significantly improved color contrast sensitivity for the blue visual axis among those 40 years old and older. Human aging is a major societal problem, and the retina ages faster than other organs, partly due to its high metabolic rate, Harpreet Shinhmar, MSc, from the Institute of Ophthalmology, University College London, and colleagues wrote. Here, 30% of central rods die, and cone...

>Read More

Fluocinolone acetonide implant increases resolution of macular edema through 36 months

Patients with noninfectious uveitis affecting the posterior segment who were treated with a fluocinolone acetonide intravitreal implant experienced beneficial effects on macular edema through 36 months. In-office injection of the fluocinolone acetonide intravitreal implant improved inflammatory control, increased the resolution of macular edema with the anticipated positive impact on vision and had a manageable safety profile, Seenu M. Hariprasad, MD, said at the virtual American Society of Reti...

>Read More

CooperVision expands business with GP Specialists

CooperVision expanded its efforts in addressing myopia through the acquisition of C&E GP Specialists Inc., the company announced in a press release. Weve been focused for many years on addressing myopia, and we take great pride in the signicant number of design options we oer ... Im pleased this eort will continue as we become part of CooperVision, which is a clear leader in the market, Steve Wagner, former president of GP Specialists, said in the release. Earning a reputation for customized ort...

>Read More

Artificial intelligence hype currently exceeding capability in medicine

Artificial intelligence in medicine is currently in the infancy stage of development, but in 10 to 20 years, the capability of the technology will catch up to the hype, a speaker said at Octanes virtual Ophthalmology Technology Summit. In the future, ophthalmologists will have to learn about AI, or youll be vulnerable to ophthalmologists who actually know AI, keynote speaker Anthony Chang, MD, MBA, MPH, MS, chief intelligence and innovation officer at Childrens Hospital of Orange County, said at...

>Read More